Menu
Search
|

Menu

Close
X

Allergan plc AGN.N (New York Stock Exchange)

139.07 USD
+0.40 (+0.29%)
As of Feb 15
chart
Previous Close 138.67
Open 140.03
Volume 574,473
3m Avg Volume 688,164
Today’s High 140.03
Today’s Low 138.33
52 Week High 197.00
52 Week Low 125.84
Shares Outstanding (mil) 334.31
Market Capitalization (mil) 69,117.80
Forward P/E --
Dividend (Yield %) 0.70 ( 1.35 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.10 Mean rating from 21 analysts

KEY STATS

Revenue (mm, USD)
FY18
15,787
FY17
15,941
FY16
14,571
EPS (USD)
FY18
-15.331
FY17
-20.331
FY16
-3.123
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.70
Price to Sales (TTM)
vs sector
4.59
6.29
Price to Book (MRQ)
vs sector
0.98
5.26
Price to Cash Flow (TTM)
vs sector
23.62
24.98
Total Debt to Equity (MRQ)
vs sector
40.20
16.12
LT Debt to Equity (MRQ)
vs sector
35.15
11.38
Return on Investment (TTM)
vs sector
-3.08
14.45
Return on Equity (TTM)
vs sector
-5.61
15.96

EXECUTIVE LEADERSHIP

Brenton Saunders
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $1,232,820.00
Bonus: $8,752,500.00
Matthew Walsh
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Karen Ling
Chief Human Resource Officer, Since 2016
Salary: --
Bonus: --
Wayne Swanton
Executive Vice President - Global Operations, Since 2017
Salary: --
Bonus: --
James D'Arecca
Chief Accounting Officer, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Clonshaugh Business And Technolo
DUBLIN     D17 E400

Phone: +35321.65235000

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products. The US General Medicine segment includes sales relating to branded products within the United States that do not fall into the US Specialized Therapeutics business units, including Central Nervous System, Gastrointestinal, Women's Health, Anti-Infectives and Diversified Brands. The International segment includes sales relating to products sold outside the United States.

SPONSORED STORIES